Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: Comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole

Digestive Diseases and Sciences

Volumn 45, Issue 1, 2000, Pages 77-82

  Miwa, Hiroto ^a   Yamada, Toshio ^a   Sato, Kenji ^a   Ohta, Kazuki ^a   Ohkura, Ryuichi ^a   Murai, Toshio ^a   Nagahara, Akihito ^a   Takei, Yoshiyuki ^a   Ogihara, Tatsuo ^a   Sato, Nobuhiro ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Amoxicillin; Clarithromycin; Cure therapy; Helicobacter pylori; Rabeprazole

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROTON PUMPS; PROTON-TRANSLOCATING ATPASES;

EID: 0033998467     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005409310412     Document Type: Article

References (30)

1. 1. Sung JJS, Chung S, Ling TKW, Yung MY, Leung VKS, Ng EKW, Li MKK, Cheng AFB, Li AKC: Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 332:139-142, 1995
2. 2. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schütze K, Taufer M, Wurzer H: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328:308-312, 1993
3. 3. Watanabe T, Toda M, Nagai H, et al: H. pylori infection induces gastric cancer in mongolian gerbils. Am J Gastroenterol 115:642-648, 1998
4. 4. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M: Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 58(19):4255-4259, 1998
5. 5. Nobre-Leitao C, Lage P, Cravo M, Cabecadas J, Chaves P, Alberto-Santos A, Correia J, Soares J, Costa-Mira F: Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.Am J Gastroenterol 93(5):732-736, 1998
6. 6. Pounder RE: New developments in Helicobacter pylori eradication therapy. Scand J Gastroenterol Suppl 223:S43-S45, 1997
7. 7. Unge P: What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 113:S131-S148, 1997
8. 8. Sharma VK, Vasudeva R, Howden CW: A national survey of gastroenterologists' current opinions and practices related to H. pylori. Am J Gastroenterol 93(9):A1647, 1998
9. 9. Miwa H, Ohkura R, Murai T, Nagahara A, Yamada T, Ogihara T, Watanabe S, Sato N: Effectiveness of OAC therapy for H. pylori infection in Japanese population. Helicobacter 3(2):132-138, 1998
10. 10. Miwa H, Nagahara A, Sato K, Ohkura R, Murai T, Watanabe S, Sato N: Efficacy of 1 week PPI/AC therapy for H. pylori infection in the Japanese population. 1998 (in press)
11. 11. Miwa H, Okura R, Murai T, Sato K, Nagahara A, Hirai S, Watanabe S, Sato N: Impact of rabeprazole, a new proton pump inhibitor, in PPI/AC therapy for Helicobacter pylori infection. Aliment Pharmcol Ther 1999 (in press)
12. 13C urea breath test for detection of Helicobacter pylori infection with fasting subjects. Helicobacter 2(2):82-85, 1997
13. 13C urea breath test for detection of H. pylori infection in fasting patients. J Gastroenterol Hepatol 13:1022-1026, 1998
14. 13C]-urea breath test for assessment of cure of Helicobacter pylori infection at 1 month after treatment. J Clin Gastroenterol 27(suppl 1):SI50-S153, 1998
15. 13C urea breath test to confirm eradication of Helicobacter pylori. Am J Gastroenterol 90(2):224-226, 1995
16. 16. Lind T, Veldhuyzen van Zanten S, Unge P, et al: Eradication of Helicobacter pylori using one-week triple therapy combining omeprazole with two antimicrobials: MACH 1 study. Helicobacter 1(3):138-144, 1996
17. 17. Working Party of the European Helicobacter pylori Study Group: Statistical annex: Statistical aspects of clinical trials in Helicobacter pylori infection. Gut 41(suppl 2):S19-S23, 1997
18. 18. Lind T, Bardhan KD, Bayerdörffer E, et al: The MACH 2 study: Optimal Helicobacter pylori therapy needs omeprazole and can be assessed by UBT. Gastroenterology 112(4):A200, 1997
19. + ATPase. Biochem Pharmacol 49:1729-1934, 1995
20. 20. Fujisaki H, Shibata H, Oketani K, et al: Effects of proton pump inhibitor, E3810, on gastric secretion and gastric and dudenal ulcers or erosions in rats. Drug Invest 2:328-332, 1991
21. 21. Fujisaki H, Shibata H, Oketani K, Murakami M, Fujimoto M, Wakabayashi T, Yamatsu I, Yamaguchi M, Sakai H, Takeguchi N: Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Biochem Pharmacol 5;42(2):321-328, 1991
22. 22. Park JB, Imamura L, Kobashi K: Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole. Biol Pharm Bull 19(2):182-187, 1996
23. 23. Hirai M, Azuma T, Ito S, Kato T, Kohli Y: A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori. J Gastroenterol 30(4):461-464, 1995
24. 24. Stack WA, Knifton A, Thirlwell D, Cockayne A, Jenkins D, Hawkey CJ, Atherton JC: Safety and efficacy of rabeprazole in combination with four antibiotic regimens for eradication of Helicobacter pylori in patients with chronic gastritis with or without oeotic ulceration. Am J Gastroenterol 93(10):1909-1913, 1998
25. 25. Jurima M, Inaba T, Kadar D, Kalow W: Genetic polymorphism of mephenyton p(4′)-hydroxylation: Difference between orientals and caucasians. Br J Clin Pharmacol 19:483-487, 1985
26. 26. Miyaji H, Ito S, Azuma T, et al: The prevalence of the drug resistance in Helicobacter pylori and the effect of the resistance on the eradication therapy in Japan. Gastroenterology 112(4):A222, 1997
27. 27. Axon T: The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori, an update. Scand J Gastroenterol 205:S31-S37, 1994
28. 28. Yamagata S, Ishimori A, Sato H, Ishihara K, Masuda M, Kasugai T, Yoshitoshi Y, Takahashi T, Wada T: Secretory function of the stomach of Japanese with endoscopically normal gastric mucosa. Gastroenterol Jpn 10(2):162-167, 1975
29. 29. Hongo M, Kimpara T, Moriyama S, Ohara S, Sone S, Tamura T, Asaki S, Toyota T: Efect of rabeprazole, a novel proton pump inhibitor, on intragastríc pH in healthy volunteers. Tohoku J Exp Med 1998 (in press)
30. 30. Williams MP, Sercombe J, Hamilton MI, Pounder RE: A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentration in young healthy male subjects. Aliment Pharmacol Ther 12:1079-1089, 1998